CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.
logo
Font
Back color
Site version
logo
  • In all sections
  • In medicines
  • In research
  • In news
  • Education hub
Often searched for

Glycine-Darnitsa

Nervous system agents
Decreased intellectual work capacity. Stressful situations and psycho-emotional tension (during exams, in conflict situations). Deviant behaviors of children and adults. Functional and organic diseases of the nervous system (neuroses, neurosis-like conditions, vegetative-vascular dystonia, consequences of neuroinfection, traumatic brain injury, perinatal and other forms of encephalopathy, including of alcoholic origin) accompanied by excessive excitability, mood swings, decreased intellectual work capacity, sleep disturbance. Ischemic stroke and cerebrovascular disorders.
Characteristics of the productу:
    • Release formTablet with chamfer for division
    • ChildrenAllowed from 3 years
    • PregnantContraindicated
    • NursingContraindicated
    • Release categoryNon-prescription
    • With alcoholReduces the toxic effect of alcohol
    • DriversWith caution
    • Temperature storage conditionsNot higher than 25 °С
    • Qualitative and quantitative composition:
    • Pharmaceutical form
    • Pharmacotherapeutic group
    • Pharmacological properties.
    • Clinical particulars
    • Therapeutic indications.
    • Contraindications.
    • Interaction with other medicinal products and other forms of interaction.
    • Special warnings and precautions for use.
    • Posology and method of administration.
    • Overdose.
    • Undesirable effects.
    • Shelf life.
    • Special precautions for storage
    • Nature and contents of container
    • Category of release
    • Manufacturer
    • The manufacturer's location and address of the place of business
    • Date of last revision